artesunic acid has been researched along with Uterine Cervical Neoplasms in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clark, KT; Donovan, MJ; Frantz, PS; Fu, J; Levinson, K; Maldonado, L; Plesa, M; Sanders, SA; Sauter, ME; Shay, ME; Trimble, CL | 1 |
| Bu, XH; Huang, AH; Huang, JX; Liu, ZN; Luan, ZY; Qian, H; Sha, M; Wang, J; Wang, XX; Wu, YQ; Xu, XL; Ye, J; Ye, LH; Yuan, DL; Zhang, LX | 1 |
| Cao, H; Cao, J; Ji, R; Lu, Z; Luo, J; Tang, Y; Yang, H; Zhang, S; Zhou, X; Zhou, Y; Zhu, W | 1 |
| Huang, J; Li, X; Lin, M; Luan, Z; Qian, H; Sha, M; Ye, L; Yuan, D; Zhang, L | 1 |
| Saiki, I; Sakurai, H; Thanaketpaisarn, O; Waiwut, P | 1 |
1 trial(s) available for artesunic acid and Uterine Cervical Neoplasms
| Article | Year |
|---|---|
A first-in-human proof-of-concept trial of intravaginal artesunate to treat cervical intraepithelial neoplasia 2/3 (CIN2/3).
Topics: Administration, Intravaginal; Adult; Antineoplastic Agents; Artesunate; Dose-Response Relationship, Drug; Female; Humans; Papillomaviridae; Papillomavirus Infections; Proof of Concept Study; Self Administration; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms | 2020 |
4 other study(ies) available for artesunic acid and Uterine Cervical Neoplasms
| Article | Year |
|---|---|
Artesunate exerts an anti-immunosuppressive effect on cervical cancer by inhibiting PGE2 production and Foxp3 expression.
Topics: Animals; Artemisinins; Artesunate; Dinoprostone; Female; Forkhead Transcription Factors; Gene Expression Regulation, Neoplastic; HeLa Cells; Humans; Immune Tolerance; Jurkat Cells; Mice; Mice, Inbred C57BL; Uterine Cervical Neoplasms | 2014 |
Artemisinin derivative artesunate induces radiosensitivity in cervical cancer cells in vitro and in vivo.
Topics: Animals; Artemisinins; Artesunate; Carcinoma; Female; HeLa Cells; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Radiation Tolerance; Radiation-Sensitizing Agents; Tumor Cells, Cultured; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays | 2014 |
Downregulation of HOTAIR Expression Mediated Anti-Metastatic Effect of Artesunate on Cervical Cancer by Inhibiting COX-2 Expression.
Topics: Animals; Antineoplastic Agents; Artemisinins; Artesunate; Cell Line, Tumor; Cell Movement; Cyclooxygenase 2; Dinoprostone; Down-Regulation; Female; Gene Expression Regulation, Neoplastic; HeLa Cells; Humans; Immunoprecipitation; Lung Neoplasms; Mice; Mice, Nude; Protein Binding; RNA Interference; RNA, Long Noncoding; RNA, Small Interfering; Transplantation, Heterologous; Uterine Cervical Neoplasms | 2016 |
Artesunate enhances TRAIL-induced apoptosis in human cervical carcinoma cells through inhibition of the NF-κB and PI3K/Akt signaling pathways.
Topics: Antineoplastic Agents; Apoptosis; Artemisinins; Artesunate; Caspase 3; Cell Survival; Drug Synergism; Female; HeLa Cells; Humans; NF-kappa B; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Signal Transduction; TNF-Related Apoptosis-Inducing Ligand; Uterine Cervical Neoplasms | 2011 |